Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tolerability and Pharmacokinetics of Alvelestat in COPD
NCT00703391Phase 2Completed
- Sponsor
- AstraZeneca
- Start
- Jun 2008
- Primary completion
- Sep 2008
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of alvelestat in chronic obstructive pulmonary disease (COPD), sponsored by AstraZeneca. Started Jun 2008; status: completed.
02
Drugs
alvelestat
03
Conditions
chronic obstructive pulmonary disease (COPD)
Beyond the preview
Go deeper on NCT00703391.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00703391.